Recent News

• 03.04.2025 - TD Cowen 45th Annual Health Care Conference
• 02.26.2025 - Theravance Biopharma Fourth Quarter 2024 Earnings Results Call
• 02.26.2025 - Theravance Biopharma Fourth Quarter 2024 Earnings Results Call
• 02.26.2025 - Theravance Biopharma, Inc. Reports Record Fourth Quarter and Full Year 2024 Financial Results
• 02.20.2025 - Theravance Biopharma to Participate in an Upcoming Investor Conference
• 02.12.2025 - Oppenheimer 35th Annual Healthcare Life Sciences Conference
• 02.12.2025 - Oppenheimer 35th Annual Healthcare Life Sciences Conference
• 02.12.2025 - Theravance Biopharma to Report Fourth Quarter and Full Year 2024 Financial Results on February 26, 2025
• 02.05.2025 - Theravance Biopharma to Participate in an Upcoming Investor Conference
• 02.05.2025 - Theravance Biopharma to Participate in an Upcoming Investor Conference

Recent Filings

• 02.26.2025 - 8-K Current report
• 02.26.2025 - EX-99.1 EX-99.1
• 02.24.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.24.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.24.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.24.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.24.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 01.23.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.21.2025 - 144 Report of proposed sale of securities